Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gunnar Gislason and Jeffrey Berger.
Gunnar Gislason
Connection Strength
0.222
Jeffrey Berger
  1. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease. J Am Coll Cardiol. 2018 10 09; 72(15):1790-1800.
    View in: PubMed
    Score: 0.049
  2. Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study. Eur Heart J Cardiovasc Pharmacother. 2018 10 01; 4(4):220-227.
    View in: PubMed
    Score: 0.049
  3. Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation. Heart. 2018 06; 104(11):912-920.
    View in: PubMed
    Score: 0.046
  4. Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study. Sci Rep. 2017 06 13; 7(1):3347.
    View in: PubMed
    Score: 0.045
  5. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation. 2012 Sep 11; 126(11):1345-54.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.